Explore more publications!
Health Times of Africa
Got News to Share?

Health Times of Africa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Africa.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 2, 2025

Young Innovations Introduces American Eagle Instruments® XP² to the U.S. Market
October 2, 2025

Young Innovations Introduces American Eagle Instruments® XP² to the U.S. Market

Indeterminate GlobeNewswire
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
October 2, 2025

Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD

Indeterminate GlobeNewswire
24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber
October 2, 2025

24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber

Indeterminate GlobeNewswire
Positron Corporation Enters Industry Partnership Agreement with MedAxiom
October 2, 2025

Positron Corporation Enters Industry Partnership Agreement with MedAxiom

Indeterminate GlobeNewswire
Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting
October 2, 2025

Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting

Indeterminate GlobeNewswire
Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa
October 2, 2025

Nacuity Pharmaceuticals Granted U.S. FDA Breakthrough Therapy Designation for NPI-001 (N-acetylcysteine amide) Tablets for the Treatment of Retinitis Pigmentosa

Indeterminate GlobeNewswire
The International Myeloma Foundation Welcomes Heather Cooper Ortner as New President & CEO
October 2, 2025

The International Myeloma Foundation Welcomes Heather Cooper Ortner as New President & CEO

Indeterminate GlobeNewswire
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
October 2, 2025

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Indeterminate GlobeNewswire
AI Model Predicts Increase in Women Likely to Get Screening Mammograms
October 2, 2025

AI Model Predicts Increase in Women Likely to Get Screening Mammograms

Indeterminate GlobeNewswire
Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization
October 2, 2025

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

Indeterminate GlobeNewswire
Sienna Senior Living Completes Acquisition in Greater Toronto Area
October 2, 2025

Sienna Senior Living Completes Acquisition in Greater Toronto Area

Indeterminate GlobeNewswire
Stride Autism Centers Opens New Bellevue, Nebraska Clinic, Expanding Access to Early Intervention ABA Therapy
October 2, 2025

Stride Autism Centers Opens New Bellevue, Nebraska Clinic, Expanding Access to Early Intervention ABA Therapy

Indeterminate GlobeNewswire
CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference
October 2, 2025

CervoMed to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

Indeterminate GlobeNewswire
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
October 2, 2025

Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025

Indeterminate GlobeNewswire
Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025
October 2, 2025

Opus Genetics to Present at Upcoming Medical and Industry Conferences in October 2025

Indeterminate GlobeNewswire
Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference
October 2, 2025

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

Indeterminate GlobeNewswire
Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
October 2, 2025

Cocrystal Pharma to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference

Indeterminate GlobeNewswire
BioCardia Regains Compliance with Nasdaq Listing Requirements
October 2, 2025

BioCardia Regains Compliance with Nasdaq Listing Requirements

Indeterminate GlobeNewswire
ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer
October 2, 2025

ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire
Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing
October 2, 2025

Starton Therapeutics Announces Promotion of Rod Hartwig to Vice President of Research and Development and Manufacturing

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions